v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,051,134      
Balance, beginning of period (in shares) at Aug. 31, 2024   20,051,134      
Balance, beginning of period at Aug. 31, 2024 $ 182,431 $ 20 $ 152,308 $ 30,354 $ (251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   28,920      
Exercise of stock options 288   288    
Stock-based compensation 1,673   1,673    
Shares issued to Directors for services (in shares)   4,960      
Shares issued to Directors for services 135   135    
Net income (loss) 206     206  
Other comprehensive income (loss) (38)       (38)
Balance, end of period at Nov. 30, 2024 184,695 $ 20 154,404 30,560 (289)
Balance, beginning of period (in shares) at Aug. 31, 2024   20,051,134      
Balance, beginning of period at Aug. 31, 2024 182,431 $ 20 152,308 30,354 (251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (64,037)        
Balance, end of period at May. 31, 2025 123,779 $ 20 157,716 (33,683) (274)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,085,014      
Balance, beginning of period (in shares) at Nov. 30, 2024   20,085,014      
Balance, beginning of period at Nov. 30, 2024 184,695 $ 20 154,404 30,560 (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   22,096      
Exercise of stock options 28   28    
Stock-based compensation 1,642   1,642    
Shares issued to Directors for services (in shares)   3,935      
Shares issued to Directors for services 135   135    
Net income (loss) 3,074     3,074  
Other comprehensive income (loss) (26)       (26)
Balance, end of period at Feb. 28, 2025 189,548 $ 20 156,209 33,634 (315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,111,045      
Balance, beginning of period (in shares) at Feb. 28, 2025   20,111,045      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,206      
Exercise of stock options 7   7    
Stock-based compensation 1,365   1,365    
Shares issued to Directors for services (in shares)   3,930      
Shares issued to Directors for services 135   135    
Net income (loss) (67,317)     (67,317)  
Other comprehensive income (loss) 41       41
Balance, end of period at May. 31, 2025 123,779 $ 20 157,716 (33,683) (274)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,116,181      
Balance, end of period (in shares)   20,137,480      
Balance, beginning of period (in shares) at Aug. 31, 2025   20,137,480      
Balance, beginning of period at Aug. 31, 2025 124,801 $ 20 159,416 (34,364) (271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   250      
Exercise of stock options 2   2    
Stock-based compensation 1,490   1,490    
Shares issued to Directors for services (in shares)   8,855      
Shares issued to Directors for services 150   150    
Net income (loss) 676     676  
Other comprehensive income (loss) (6)       (6)
Balance, end of period at Nov. 30, 2025 127,113 $ 20 161,058 (33,688) (277)
Balance, beginning of period (in shares) at Aug. 31, 2025   20,137,480      
Balance, beginning of period at Aug. 31, 2025 124,801 $ 20 159,416 (34,364) (271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 8,786        
Balance, end of period at May. 31, 2026 139,035 $ 20 164,863 (25,578) (270)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,146,585      
Balance, beginning of period (in shares) at Nov. 30, 2025   20,146,585      
Balance, beginning of period at Nov. 30, 2025 127,113 $ 20 161,058 (33,688) (277)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   51,793      
Exercise of stock options 474   474    
Stock-based compensation 1,524   1,524    
Shares issued to Directors for services (in shares)   7,104      
Shares issued to Directors for services 120   120    
Net income (loss) 4,535     4,535  
Other comprehensive income (loss) 5       5
Balance, end of period at Feb. 28, 2026 133,771 $ 20 163,176 (29,153) (272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,205,482      
Balance, beginning of period (in shares) at Feb. 28, 2026   20,205,482      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   2,488      
Exercise of stock options 10   10    
Stock-based compensation 1,557   1,557    
Shares issued to Directors for services (in shares)   8,468      
Shares issued to Directors for services 120   120    
Net income (loss) 3,575     3,575  
Other comprehensive income (loss) 2       2
Balance, end of period at May. 31, 2026 $ 139,035 $ 20 $ 164,863 $ (25,578) $ (270)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance, end of period (in shares)   20,216,438